Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dental Caries | 5 | 2016 | 25 | 1.300 |
Why?
|
Humans | 88 | 2024 | 18058 | 1.210 |
Why?
|
Genetic Carrier Screening | 6 | 2018 | 22 | 1.190 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2019 | 60 | 1.160 |
Why?
|
Female | 73 | 2024 | 12838 | 1.110 |
Why?
|
Male | 57 | 2021 | 10173 | 1.030 |
Why?
|
Community Health Centers | 8 | 2021 | 109 | 0.970 |
Why?
|
Genetic Counseling | 8 | 2023 | 36 | 0.940 |
Why?
|
Early Detection of Cancer | 5 | 2023 | 510 | 0.910 |
Why?
|
Surveys and Questionnaires | 13 | 2019 | 1346 | 0.880 |
Why?
|
Middle Aged | 48 | 2023 | 8073 | 0.880 |
Why?
|
Adult | 49 | 2023 | 7696 | 0.870 |
Why?
|
Genetic Diseases, Inborn | 3 | 2018 | 12 | 0.850 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2020 | 40 | 0.820 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 643 | 0.800 |
Why?
|
Depression | 4 | 2020 | 512 | 0.760 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2022 | 249 | 0.750 |
Why?
|
Genetic Testing | 7 | 2023 | 89 | 0.750 |
Why?
|
Family | 3 | 2018 | 119 | 0.720 |
Why?
|
Family Planning Services | 3 | 2017 | 27 | 0.720 |
Why?
|
Genome, Human | 3 | 2016 | 41 | 0.710 |
Why?
|
Serotonin Uptake Inhibitors | 1 | 2020 | 75 | 0.700 |
Why?
|
Graves Ophthalmopathy | 4 | 2020 | 4 | 0.680 |
Why?
|
Xylitol | 3 | 2013 | 4 | 0.680 |
Why?
|
Curriculum | 3 | 2024 | 42 | 0.680 |
Why?
|
Public Health | 1 | 2019 | 80 | 0.670 |
Why?
|
Pit and Fissure Sealants | 2 | 2016 | 8 | 0.660 |
Why?
|
Aged | 33 | 2020 | 6258 | 0.640 |
Why?
|
Antipsychotic Agents | 5 | 2016 | 57 | 0.620 |
Why?
|
Gynecology | 3 | 2024 | 24 | 0.590 |
Why?
|
Preconception Care | 5 | 2018 | 45 | 0.590 |
Why?
|
Personal Satisfaction | 1 | 2016 | 13 | 0.580 |
Why?
|
Sweetening Agents | 2 | 2013 | 7 | 0.560 |
Why?
|
Evidence-Based Practice | 3 | 2016 | 53 | 0.560 |
Why?
|
Orthodontic Anchorage Procedures | 1 | 2016 | 1 | 0.560 |
Why?
|
Dental Implants | 1 | 2016 | 3 | 0.560 |
Why?
|
Cariostatic Agents | 2 | 2013 | 7 | 0.560 |
Why?
|
Chiropractic | 2 | 2012 | 12 | 0.550 |
Why?
|
Critical Care | 1 | 2016 | 72 | 0.540 |
Why?
|
Breast Neoplasms | 8 | 2022 | 1023 | 0.510 |
Why?
|
Young Adult | 16 | 2023 | 2479 | 0.510 |
Why?
|
Depressive Disorder, Major | 1 | 2016 | 128 | 0.500 |
Why?
|
Quality of Health Care | 2 | 2016 | 346 | 0.490 |
Why?
|
Decision Making | 9 | 2020 | 204 | 0.490 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 4 | 2018 | 70 | 0.480 |
Why?
|
Health Promotion | 4 | 2021 | 295 | 0.480 |
Why?
|
Health Status | 4 | 2016 | 331 | 0.480 |
Why?
|
Sequence Analysis, DNA | 4 | 2016 | 38 | 0.450 |
Why?
|
Genomics | 6 | 2020 | 65 | 0.450 |
Why?
|
Adolescent | 16 | 2021 | 3714 | 0.440 |
Why?
|
Treatment Outcome | 15 | 2021 | 1259 | 0.420 |
Why?
|
Practice Patterns, Physicians' | 4 | 2020 | 351 | 0.420 |
Why?
|
Occult Blood | 3 | 2023 | 159 | 0.410 |
Why?
|
Cost-Benefit Analysis | 5 | 2019 | 264 | 0.380 |
Why?
|
Pregnancy | 7 | 2024 | 1484 | 0.380 |
Why?
|
Behavior Therapy | 3 | 2021 | 152 | 0.380 |
Why?
|
Reminder Systems | 2 | 2023 | 84 | 0.380 |
Why?
|
Motivation | 3 | 2019 | 133 | 0.380 |
Why?
|
Weight Loss | 5 | 2015 | 296 | 0.380 |
Why?
|
Obesity | 5 | 2023 | 839 | 0.370 |
Why?
|
Overweight | 5 | 2016 | 272 | 0.370 |
Why?
|
Attitude to Health | 5 | 2015 | 179 | 0.370 |
Why?
|
Aged, 80 and over | 12 | 2020 | 1956 | 0.370 |
Why?
|
Occupational Health | 2 | 2007 | 20 | 0.360 |
Why?
|
Cystectomy | 2 | 2019 | 8 | 0.350 |
Why?
|
Decision Support Techniques | 2 | 2020 | 92 | 0.350 |
Why?
|
Life Style | 4 | 2015 | 329 | 0.350 |
Why?
|
Mass Screening | 3 | 2023 | 678 | 0.350 |
Why?
|
Resistance Training | 4 | 2012 | 6 | 0.330 |
Why?
|
United States | 14 | 2021 | 4119 | 0.320 |
Why?
|
Patient Compliance | 3 | 2019 | 303 | 0.320 |
Why?
|
Child | 11 | 2021 | 2519 | 0.320 |
Why?
|
Cholesterol | 2 | 2018 | 112 | 0.300 |
Why?
|
Reproducibility of Results | 3 | 2019 | 394 | 0.290 |
Why?
|
Risk Assessment | 7 | 2019 | 1137 | 0.290 |
Why?
|
Biomarkers | 4 | 2020 | 306 | 0.280 |
Why?
|
Weight Reduction Programs | 2 | 2016 | 55 | 0.270 |
Why?
|
Quality Improvement | 3 | 2023 | 205 | 0.260 |
Why?
|
Mental Disorders | 4 | 2016 | 290 | 0.260 |
Why?
|
Child Behavior | 4 | 2018 | 25 | 0.260 |
Why?
|
Prognosis | 4 | 2020 | 619 | 0.260 |
Why?
|
Psychotic Disorders | 3 | 2015 | 47 | 0.260 |
Why?
|
Emigrants and Immigrants | 3 | 2014 | 31 | 0.250 |
Why?
|
Telephone | 2 | 2023 | 175 | 0.250 |
Why?
|
Primary Health Care | 4 | 2020 | 843 | 0.250 |
Why?
|
Parents | 2 | 2020 | 308 | 0.250 |
Why?
|
End Stage Liver Disease | 2 | 2015 | 11 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 177 | 0.250 |
Why?
|
Follow-Up Studies | 7 | 2020 | 1255 | 0.240 |
Why?
|
Risk Factors | 7 | 2023 | 3394 | 0.240 |
Why?
|
Psychology, Child | 2 | 2005 | 7 | 0.240 |
Why?
|
Research Design | 4 | 2020 | 393 | 0.240 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2023 | 7 | 0.240 |
Why?
|
Menopause | 2 | 2024 | 72 | 0.240 |
Why?
|
Nursing Homes | 2 | 2014 | 9 | 0.240 |
Why?
|
Obstetrics | 1 | 2024 | 24 | 0.230 |
Why?
|
Adaptation, Psychological | 2 | 2005 | 82 | 0.230 |
Why?
|
Body Mass Index | 5 | 2021 | 961 | 0.230 |
Why?
|
Diabetes Mellitus | 3 | 2017 | 526 | 0.230 |
Why?
|
Survivors | 4 | 2012 | 157 | 0.230 |
Why?
|
Bone Density | 3 | 2012 | 98 | 0.230 |
Why?
|
Internship and Residency | 1 | 2024 | 55 | 0.230 |
Why?
|
Psychology, Adolescent | 1 | 2003 | 15 | 0.220 |
Why?
|
Pregnancy Complications | 2 | 2016 | 193 | 0.220 |
Why?
|
Delivery of Health Care | 3 | 2019 | 445 | 0.220 |
Why?
|
Substance Abuse Detection | 1 | 2002 | 19 | 0.220 |
Why?
|
Cross-Sectional Studies | 8 | 2021 | 1309 | 0.210 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 613 | 0.210 |
Why?
|
Mothers | 4 | 2018 | 110 | 0.210 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 42 | 0.210 |
Why?
|
Marijuana Abuse | 1 | 2002 | 39 | 0.210 |
Why?
|
Counseling | 4 | 2016 | 199 | 0.210 |
Why?
|
Health Literacy | 1 | 2022 | 45 | 0.210 |
Why?
|
Exome | 3 | 2016 | 25 | 0.210 |
Why?
|
Organ Size | 1 | 2021 | 16 | 0.210 |
Why?
|
Disease Progression | 2 | 2020 | 255 | 0.210 |
Why?
|
Prospective Studies | 8 | 2023 | 1294 | 0.210 |
Why?
|
Incidental Findings | 3 | 2016 | 30 | 0.200 |
Why?
|
Liver | 1 | 2021 | 33 | 0.200 |
Why?
|
Safety-net Providers | 2 | 2020 | 57 | 0.200 |
Why?
|
Asian Americans | 2 | 2013 | 184 | 0.200 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2014 | 123 | 0.200 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2012 | 42 | 0.200 |
Why?
|
Exercise Therapy | 2 | 2012 | 70 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 397 | 0.200 |
Why?
|
Patient Satisfaction | 3 | 2019 | 233 | 0.200 |
Why?
|
Oregon | 5 | 2020 | 195 | 0.200 |
Why?
|
Quality of Life | 3 | 2019 | 509 | 0.200 |
Why?
|
Counselors | 1 | 2020 | 1 | 0.190 |
Why?
|
Receptors, Thyrotropin | 1 | 2020 | 2 | 0.190 |
Why?
|
Urogenital System | 1 | 2020 | 2 | 0.190 |
Why?
|
Vulvovaginitis | 1 | 2020 | 3 | 0.190 |
Why?
|
Urologic Diseases | 1 | 2020 | 8 | 0.190 |
Why?
|
Electronic Health Records | 5 | 2017 | 734 | 0.190 |
Why?
|
Clinical Competence | 3 | 2024 | 109 | 0.190 |
Why?
|
Depressive Disorder | 2 | 2018 | 233 | 0.180 |
Why?
|
Sleep Hygiene | 1 | 2020 | 4 | 0.180 |
Why?
|
Trauma Severity Indices | 1 | 2020 | 9 | 0.180 |
Why?
|
Pediatric Obesity | 1 | 2021 | 75 | 0.180 |
Why?
|
Dyslipidemias | 2 | 2017 | 63 | 0.180 |
Why?
|
Patient Navigation | 1 | 2019 | 17 | 0.180 |
Why?
|
Stress, Psychological | 3 | 2018 | 145 | 0.180 |
Why?
|
Urinary Diversion | 1 | 2019 | 3 | 0.180 |
Why?
|
Documentation | 1 | 2020 | 45 | 0.180 |
Why?
|
Heterozygote | 2 | 2016 | 29 | 0.170 |
Why?
|
Terminology as Topic | 2 | 2016 | 21 | 0.170 |
Why?
|
Referral and Consultation | 2 | 2019 | 178 | 0.170 |
Why?
|
Anxiety Disorders | 1 | 2019 | 91 | 0.170 |
Why?
|
Maxilla | 2 | 2016 | 2 | 0.170 |
Why?
|
Mandible | 2 | 2016 | 4 | 0.170 |
Why?
|
Health Policy | 1 | 2020 | 135 | 0.160 |
Why?
|
Cancer Survivors | 1 | 2019 | 88 | 0.160 |
Why?
|
Neonatal Screening | 1 | 2018 | 13 | 0.160 |
Why?
|
Antidepressive Agents | 2 | 2018 | 162 | 0.160 |
Why?
|
Neoplasms | 2 | 2020 | 464 | 0.160 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 35 | 0.160 |
Why?
|
Double-Blind Method | 3 | 2013 | 160 | 0.160 |
Why?
|
Mental Health Services | 2 | 2013 | 159 | 0.150 |
Why?
|
Colonoscopy | 1 | 2019 | 265 | 0.150 |
Why?
|
Pilot Projects | 5 | 2019 | 235 | 0.150 |
Why?
|
Health Expenditures | 1 | 2018 | 81 | 0.150 |
Why?
|
American Heart Association | 1 | 2017 | 49 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 393 | 0.150 |
Why?
|
Smoking | 1 | 2020 | 465 | 0.140 |
Why?
|
Primary Prevention | 1 | 2017 | 77 | 0.140 |
Why?
|
Northwestern United States | 1 | 2016 | 47 | 0.140 |
Why?
|
Postnatal Care | 1 | 2016 | 22 | 0.140 |
Why?
|
Smoking Cessation | 2 | 2016 | 198 | 0.140 |
Why?
|
Glucocorticoids | 1 | 2016 | 15 | 0.140 |
Why?
|
Liver Diseases | 1 | 2016 | 25 | 0.140 |
Why?
|
Root Caries | 2 | 2013 | 3 | 0.140 |
Why?
|
DMF Index | 2 | 2013 | 4 | 0.140 |
Why?
|
Fluorides | 2 | 2013 | 5 | 0.140 |
Why?
|
Dental Caries Susceptibility | 2 | 2013 | 11 | 0.140 |
Why?
|
Weight Gain | 2 | 2016 | 180 | 0.140 |
Why?
|
Placebos | 2 | 2013 | 20 | 0.140 |
Why?
|
Laboratories | 1 | 2016 | 23 | 0.140 |
Why?
|
Truth Disclosure | 1 | 2016 | 19 | 0.140 |
Why?
|
Treatment Refusal | 1 | 2016 | 38 | 0.140 |
Why?
|
Drug Utilization | 1 | 2016 | 134 | 0.140 |
Why?
|
Patient Participation | 2 | 2019 | 143 | 0.140 |
Why?
|
Genetic Variation | 1 | 2016 | 87 | 0.130 |
Why?
|
Palliative Care | 1 | 2016 | 57 | 0.130 |
Why?
|
Medical Records | 1 | 2016 | 108 | 0.130 |
Why?
|
Body Image | 1 | 2015 | 22 | 0.130 |
Why?
|
Mutation | 1 | 2016 | 129 | 0.130 |
Why?
|
Health Education | 2 | 2013 | 118 | 0.130 |
Why?
|
Preimplantation Diagnosis | 1 | 2015 | 3 | 0.130 |
Why?
|
Social Determinants of Health | 1 | 2016 | 40 | 0.130 |
Why?
|
Prostatectomy | 1 | 2015 | 79 | 0.130 |
Why?
|
Health Care Costs | 2 | 2010 | 253 | 0.130 |
Why?
|
Risk Reduction Behavior | 3 | 2016 | 114 | 0.130 |
Why?
|
Critical Illness | 1 | 2016 | 53 | 0.130 |
Why?
|
Self Efficacy | 1 | 2015 | 75 | 0.130 |
Why?
|
Biomedical Research | 1 | 2016 | 89 | 0.130 |
Why?
|
Patient Education as Topic | 2 | 2015 | 215 | 0.130 |
Why?
|
Communication | 3 | 2022 | 205 | 0.130 |
Why?
|
Muscle Strength | 2 | 2011 | 12 | 0.130 |
Why?
|
Intensive Care Units | 1 | 2016 | 103 | 0.130 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 324 | 0.130 |
Why?
|
Prenatal Care | 1 | 2016 | 136 | 0.130 |
Why?
|
Glycated Hemoglobin A | 1 | 2016 | 231 | 0.130 |
Why?
|
Psychometrics | 2 | 2012 | 120 | 0.130 |
Why?
|
Group Processes | 1 | 2014 | 12 | 0.120 |
Why?
|
Health Facility Administrators | 1 | 2014 | 3 | 0.120 |
Why?
|
Biomarkers, Tumor | 1 | 2015 | 144 | 0.120 |
Why?
|
Patient Reported Outcome Measures | 3 | 2019 | 56 | 0.120 |
Why?
|
Receptors, Cytokine | 1 | 2014 | 2 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2014 | 3 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 26 | 0.120 |
Why?
|
Recovery of Function | 1 | 2013 | 28 | 0.120 |
Why?
|
Affective Disorders, Psychotic | 1 | 2013 | 10 | 0.120 |
Why?
|
Postmenopause | 2 | 2012 | 266 | 0.120 |
Why?
|
Patient Outcome Assessment | 1 | 2013 | 29 | 0.120 |
Why?
|
Pain Management | 1 | 2014 | 56 | 0.110 |
Why?
|
Nurse Administrators | 1 | 2013 | 8 | 0.110 |
Why?
|
Homes for the Aged | 1 | 2013 | 6 | 0.110 |
Why?
|
Professional Competence | 1 | 2013 | 12 | 0.110 |
Why?
|
Nurse's Role | 1 | 2013 | 8 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 742 | 0.110 |
Why?
|
Schizophrenia | 1 | 2013 | 80 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 49 | 0.110 |
Why?
|
Crowns | 1 | 2013 | 2 | 0.110 |
Why?
|
Tooth Loss | 1 | 2013 | 2 | 0.110 |
Why?
|
Dentin | 1 | 2013 | 9 | 0.110 |
Why?
|
Dental Enamel | 1 | 2013 | 9 | 0.110 |
Why?
|
Leadership | 1 | 2013 | 42 | 0.110 |
Why?
|
Students, Health Occupations | 1 | 2012 | 1 | 0.110 |
Why?
|
Dental Restoration, Permanent | 1 | 2013 | 21 | 0.110 |
Why?
|
Severity of Illness Index | 4 | 2020 | 454 | 0.110 |
Why?
|
Focus Groups | 3 | 2020 | 152 | 0.110 |
Why?
|
Educational Measurement | 1 | 2012 | 22 | 0.110 |
Why?
|
Menopause, Premature | 1 | 2012 | 3 | 0.110 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 299 | 0.110 |
Why?
|
Administration, Oral | 1 | 2013 | 81 | 0.110 |
Why?
|
Cognition | 2 | 2015 | 80 | 0.110 |
Why?
|
Self Care | 1 | 2014 | 175 | 0.110 |
Why?
|
Hand Strength | 1 | 2011 | 11 | 0.100 |
Why?
|
Alveolar Process | 1 | 2011 | 1 | 0.100 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2011 | 1 | 0.100 |
Why?
|
Cephalometry | 1 | 2011 | 2 | 0.100 |
Why?
|
Mammography | 1 | 2013 | 173 | 0.100 |
Why?
|
Linear Models | 3 | 2017 | 240 | 0.100 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 439 | 0.100 |
Why?
|
Induction Chemotherapy | 1 | 2011 | 4 | 0.100 |
Why?
|
Hip Fractures | 1 | 2012 | 70 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 10 | 0.100 |
Why?
|
Fatigue | 1 | 2011 | 35 | 0.100 |
Why?
|
Postural Balance | 1 | 2011 | 11 | 0.100 |
Why?
|
Osteoporosis | 1 | 2012 | 87 | 0.100 |
Why?
|
Dental Plaque | 1 | 2011 | 1 | 0.100 |
Why?
|
Orthodontic Appliance Design | 1 | 2011 | 1 | 0.100 |
Why?
|
Orthodontic Brackets | 1 | 2011 | 1 | 0.100 |
Why?
|
Dental Caries Activity Tests | 1 | 2011 | 2 | 0.100 |
Why?
|
HIV Infections | 1 | 2017 | 682 | 0.100 |
Why?
|
Interviews as Topic | 3 | 2019 | 327 | 0.100 |
Why?
|
Sleep Wake Disorders | 1 | 2011 | 40 | 0.100 |
Why?
|
Accidental Falls | 1 | 2011 | 42 | 0.100 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 227 | 0.100 |
Why?
|
Methadone | 1 | 2010 | 11 | 0.090 |
Why?
|
Prepaid Health Plans | 1 | 2010 | 22 | 0.090 |
Why?
|
Opiate Substitution Treatment | 1 | 2010 | 44 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2019 | 11 | 0.090 |
Why?
|
Community Health Services | 2 | 2012 | 85 | 0.090 |
Why?
|
Infant, Newborn | 3 | 2018 | 852 | 0.090 |
Why?
|
Hispanic Americans | 2 | 2021 | 431 | 0.090 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 667 | 0.090 |
Why?
|
Ethnic Groups | 3 | 2021 | 504 | 0.080 |
Why?
|
Qualitative Research | 2 | 2016 | 267 | 0.080 |
Why?
|
Time Factors | 3 | 2019 | 1114 | 0.080 |
Why?
|
Diet | 3 | 2016 | 359 | 0.080 |
Why?
|
Bacopa | 1 | 2008 | 1 | 0.080 |
Why?
|
Plant Extracts | 1 | 2008 | 14 | 0.080 |
Why?
|
Phytotherapy | 1 | 2008 | 13 | 0.080 |
Why?
|
Exercise | 4 | 2016 | 478 | 0.080 |
Why?
|
Mental Health | 1 | 2009 | 166 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2010 | 166 | 0.080 |
Why?
|
Anxiety | 1 | 2008 | 153 | 0.070 |
Why?
|
Nursing Methodology Research | 2 | 2005 | 8 | 0.070 |
Why?
|
Prevalence | 2 | 2021 | 892 | 0.070 |
Why?
|
Adolescent Behavior | 2 | 2011 | 130 | 0.070 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 86 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 328 | 0.070 |
Why?
|
California | 3 | 2016 | 2327 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 953 | 0.070 |
Why?
|
Family Health | 1 | 2005 | 47 | 0.070 |
Why?
|
Family Relations | 1 | 2005 | 18 | 0.070 |
Why?
|
Models, Psychological | 1 | 2005 | 25 | 0.060 |
Why?
|
Gestational Age | 2 | 2016 | 119 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 407 | 0.060 |
Why?
|
Mastectomy | 1 | 2005 | 36 | 0.060 |
Why?
|
Energy Intake | 2 | 2015 | 100 | 0.060 |
Why?
|
Guidelines as Topic | 2 | 2016 | 42 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2016 | 2498 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2005 | 112 | 0.060 |
Why?
|
Physical Fitness | 1 | 2004 | 73 | 0.060 |
Why?
|
Ambulatory Care | 2 | 2016 | 274 | 0.060 |
Why?
|
Vaginal Smears | 2 | 2014 | 46 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2019 | 705 | 0.060 |
Why?
|
Emotions | 1 | 2003 | 33 | 0.060 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 14 | 0.060 |
Why?
|
Random Allocation | 1 | 2002 | 42 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2023 | 59 | 0.060 |
Why?
|
Self Concept | 1 | 2003 | 40 | 0.050 |
Why?
|
Organizational Policy | 1 | 2002 | 18 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 23 | 0.050 |
Why?
|
Lipids | 1 | 2023 | 77 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2021 | 3 | 0.050 |
Why?
|
Hepatocytes | 1 | 2021 | 3 | 0.050 |
Why?
|
Weaning | 1 | 2021 | 6 | 0.050 |
Why?
|
Parturition | 1 | 2021 | 10 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2021 | 19 | 0.050 |
Why?
|
Glucose | 1 | 2021 | 30 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2012 | 162 | 0.050 |
Why?
|
Incisor | 2 | 2011 | 4 | 0.050 |
Why?
|
Data Collection | 1 | 2022 | 276 | 0.050 |
Why?
|
Alcohol Drinking | 1 | 2004 | 375 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2012 | 330 | 0.050 |
Why?
|
Syndrome | 1 | 2020 | 31 | 0.050 |
Why?
|
Immunoassay | 1 | 2020 | 9 | 0.050 |
Why?
|
Facial Asymmetry | 1 | 2020 | 1 | 0.050 |
Why?
|
European Continental Ancestry Group | 1 | 2003 | 559 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 745 | 0.050 |
Why?
|
Urologists | 1 | 2019 | 3 | 0.040 |
Why?
|
African Americans | 1 | 2003 | 485 | 0.040 |
Why?
|
Atrophy | 1 | 2019 | 6 | 0.040 |
Why?
|
Forecasting | 1 | 2020 | 77 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 83 | 0.040 |
Why?
|
Mentoring | 1 | 2019 | 28 | 0.040 |
Why?
|
Attitude | 1 | 2019 | 34 | 0.040 |
Why?
|
Washington | 1 | 2020 | 384 | 0.040 |
Why?
|
Minority Groups | 1 | 2019 | 103 | 0.040 |
Why?
|
Text Messaging | 1 | 2019 | 30 | 0.040 |
Why?
|
Medicare | 1 | 2020 | 206 | 0.040 |
Why?
|
Religion and Medicine | 1 | 2018 | 3 | 0.040 |
Why?
|
Postal Service | 1 | 2019 | 82 | 0.040 |
Why?
|
Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
Reproductive Health | 1 | 2018 | 12 | 0.040 |
Why?
|
Income | 1 | 2018 | 95 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2018 | 22 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2018 | 42 | 0.040 |
Why?
|
Drug Utilization Review | 1 | 2017 | 28 | 0.040 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2018 | 248 | 0.040 |
Why?
|
Health Services Research | 1 | 2018 | 271 | 0.040 |
Why?
|
Administration, Intravenous | 1 | 2016 | 7 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2016 | 5 | 0.040 |
Why?
|
Diet Therapy | 1 | 2016 | 12 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 12 | 0.040 |
Why?
|
Software | 1 | 2016 | 22 | 0.030 |
Why?
|
Nurses | 1 | 2016 | 34 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2017 | 160 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2015 | 18 | 0.030 |
Why?
|
Treatment Failure | 1 | 2015 | 36 | 0.030 |
Why?
|
Language | 1 | 2016 | 52 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 79 | 0.030 |
Why?
|
Inpatients | 1 | 2016 | 79 | 0.030 |
Why?
|
Prostate | 1 | 2015 | 29 | 0.030 |
Why?
|
ROC Curve | 1 | 2015 | 79 | 0.030 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2017 | 178 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2017 | 595 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 127 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 197 | 0.030 |
Why?
|
Nutritionists | 1 | 2015 | 2 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 127 | 0.030 |
Why?
|
Actigraphy | 1 | 2015 | 16 | 0.030 |
Why?
|
Death | 1 | 2015 | 10 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 692 | 0.030 |
Why?
|
Food | 1 | 2015 | 30 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2016 | 136 | 0.030 |
Why?
|
Commerce | 1 | 2015 | 49 | 0.030 |
Why?
|
Self-Help Groups | 1 | 2014 | 32 | 0.030 |
Why?
|
Self-Assessment | 1 | 2014 | 17 | 0.030 |
Why?
|
Body Weight | 1 | 2015 | 216 | 0.030 |
Why?
|
Vietnam | 1 | 2014 | 34 | 0.030 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2014 | 1 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 2 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2014 | 3 | 0.030 |
Why?
|
Doxorubicin | 1 | 2014 | 5 | 0.030 |
Why?
|
Blood Glucose | 1 | 2016 | 344 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2014 | 15 | 0.030 |
Why?
|
Fluorouracil | 1 | 2014 | 12 | 0.030 |
Why?
|
Signal Transduction | 1 | 2014 | 30 | 0.030 |
Why?
|
Sucrose | 1 | 2013 | 6 | 0.030 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2014 | 41 | 0.030 |
Why?
|
Mice | 1 | 2014 | 66 | 0.030 |
Why?
|
Comorbidity | 1 | 2016 | 618 | 0.030 |
Why?
|
Analgesics | 1 | 2014 | 28 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2013 | 43 | 0.030 |
Why?
|
Sleep | 1 | 2014 | 56 | 0.030 |
Why?
|
Toothbrushing | 1 | 2013 | 1 | 0.030 |
Why?
|
Toothpastes | 1 | 2013 | 1 | 0.030 |
Why?
|
Fluorides, Topical | 1 | 2013 | 4 | 0.030 |
Why?
|
Tablets | 1 | 2013 | 2 | 0.030 |
Why?
|
Tooth Crown | 1 | 2013 | 5 | 0.030 |
Why?
|
Registries | 1 | 2015 | 486 | 0.030 |
Why?
|
Policy Making | 1 | 2013 | 18 | 0.030 |
Why?
|
Animals | 1 | 2014 | 250 | 0.030 |
Why?
|
Self Report | 1 | 2015 | 252 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 63 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2013 | 116 | 0.030 |
Why?
|
Hypertension | 1 | 2017 | 489 | 0.030 |
Why?
|
Nursing Research | 1 | 2012 | 2 | 0.030 |
Why?
|
Femur Neck | 1 | 2012 | 5 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2012 | 20 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 160 | 0.030 |
Why?
|
Body Composition | 1 | 2012 | 80 | 0.030 |
Why?
|
Hip Joint | 1 | 2012 | 4 | 0.030 |
Why?
|
Health Behavior | 1 | 2015 | 379 | 0.030 |
Why?
|
Social Support | 1 | 2014 | 211 | 0.030 |
Why?
|
Needs Assessment | 1 | 2012 | 73 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 57 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2012 | 249 | 0.030 |
Why?
|
Educational Status | 1 | 2012 | 205 | 0.030 |
Why?
|
Cadaver | 1 | 2011 | 1 | 0.030 |
Why?
|
Dental Arch | 1 | 2011 | 1 | 0.030 |
Why?
|
Dissection | 1 | 2011 | 1 | 0.030 |
Why?
|
Bicuspid | 1 | 2011 | 3 | 0.030 |
Why?
|
Molar | 1 | 2011 | 3 | 0.030 |
Why?
|
Cuspid | 1 | 2011 | 4 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2011 | 46 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 11 | 0.030 |
Why?
|
Observer Variation | 1 | 2011 | 39 | 0.030 |
Why?
|
Sleep Stages | 1 | 2011 | 3 | 0.030 |
Why?
|
Program Evaluation | 1 | 2012 | 236 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 257 | 0.020 |
Why?
|
Depth Perception | 1 | 2011 | 1 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2011 | 13 | 0.020 |
Why?
|
Gait | 1 | 2011 | 7 | 0.020 |
Why?
|
Visual Acuity | 1 | 2011 | 20 | 0.020 |
Why?
|
Dental Plaque Index | 1 | 2011 | 1 | 0.020 |
Why?
|
Tooth Demineralization | 1 | 2011 | 1 | 0.020 |
Why?
|
Elastomers | 1 | 2011 | 1 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2011 | 2 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2011 | 59 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 350 | 0.020 |
Why?
|
Bacteria | 1 | 2011 | 6 | 0.020 |
Why?
|
Hospitalization | 1 | 2016 | 813 | 0.020 |
Why?
|
Aging | 1 | 2012 | 159 | 0.020 |
Why?
|
Regression Analysis | 1 | 2011 | 319 | 0.020 |
Why?
|
Plant Preparations | 1 | 2008 | 6 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2011 | 1164 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 552 | 0.020 |
Why?
|
Incidence | 1 | 2011 | 1297 | 0.020 |
Why?
|
Internet | 1 | 2007 | 247 | 0.020 |
Why?
|
Conflict (Psychology) | 1 | 2005 | 8 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2005 | 35 | 0.020 |
Why?
|
Child Behavior Disorders | 1 | 2005 | 18 | 0.020 |
Why?
|
Sex Factors | 1 | 2004 | 634 | 0.010 |
Why?
|
Child, Preschool | 1 | 2005 | 1428 | 0.010 |
Why?
|